News
Novo Nordisk Signs OpenAI Deal to Bring Medicines to Patients Faster
Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026
Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026
Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.